FDA.reportPublic FDA data

risankizumab-rzaa 75 MG in 0.83 mL (2) Prefilled Syringe Pack

RxCUI
2166137
RxNorm name
risankizumab-rzaa 75 MG in 0.83 mL (2) Prefilled Syringe Pack
Display name
risankizumab-rzaa 75 MG in 0.83 mL (2) Prefilled Syringe Pack
Full name
risankizumab-rzaa 75 MG in 0.83 mL (2) Prefilled Syringe Pack
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:03

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761105Skyrizirisankizumab-rzaa351(a)Disc2026-06-01
761262Skyrizirisankizumab-rzaa351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SkyriziRISANKIZUMAB-RZAAAbbVie Inc.7148c8eb-b39e-e20a-6494-a6df823928582026-06-15Warnings, Adverse reactionsExact identifier
rxcui: 2166137

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
7148c8eb-b39e-e20a-6494-a6df82392858risankizumab-rzaa 75 MG in 0.83 mL (2) Prefilled Syringe PackPSN173These highlights do not include all the information needed to use SKYRIZI safely and effectively. See full prescribing information for SKYRIZI. SKYRIZI ® (risankizumab-rzaa) injection, for subcutaneous or intravenous use Initial U.S. Approval: 201920260319
7148c8eb-b39e-e20a-6494-a6df82392858{2 (0.83 ML risankizumab-rzaa 90.4 MG/ML Prefilled Syringe) } PackGPCK173These highlights do not include all the information needed to use SKYRIZI safely and effectively. See full prescribing information for SKYRIZI. SKYRIZI ® (risankizumab-rzaa) injection, for subcutaneous or intravenous use Initial U.S. Approval: 201920260319
7148c8eb-b39e-e20a-6494-a6df82392858{2 (risankizumab-rzaa 75 MG per 0.83 ML Prefilled Syringe) } PackSY173These highlights do not include all the information needed to use SKYRIZI safely and effectively. See full prescribing information for SKYRIZI. SKYRIZI ® (risankizumab-rzaa) injection, for subcutaneous or intravenous use Initial U.S. Approval: 201920260319